Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | CASP1 | P29466 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.36 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4939013 | 0.88 | CES1 (0.46) | CES1ALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL27680873 | 0.86 | CES1 (0.42) | CES1ALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL29268744 | 0.85 | CES1 (0.44) | CES1ALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL4667935 | 0.84 | CES1 (0.40) | CES1ALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL30103712 | 0.81 | CES1 (0.45) | CES1ALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL1923716 | 0.80 | ALDH1A1 (0.45) | CES1ALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL2140658 | 0.80 | DHFR (0.38) | CES1ALDH1A1HPGDHSD17B10CASP1 | |
| SCHEMBL2346874 | 0.79 | ALDH1A1 (0.53) | CES1ALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL14150465 | 0.78 | CES1 (0.40) | CES1ALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL9995293 | 0.76 | CES1 (0.58) | CES1ALDH1A1HPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080220287-A1 | White Organic Illuminating Diodes (Oleds) Based on Exciplex Double Blue Fluorescent Compounds | BASF SE (DE) | 2008-09-11 | — | — | US | claimed |
| US-7906225-B2 | Synthesis of phenyl-substituted fluoranthenes by a diesel-alder and the use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2011-03-15 | — | — | US | disclosed |
| US-20080220287-A1 | White Organic Illuminating Diodes (Oleds) Based on Exciplex Double Blue Fluorescent Compounds | BASF SE (DE) | 2008-09-11 | — | — | US | disclosed |
| EP-1673322-B1 | SYNTHESIS OF PHENYL-SUBSTITUTED FLUORANTHENES BY A DIESEL-ALDER REACTION AND THE USE THEREOF | BASF SE (DE) | 2008-04-16 | — | — | EP | disclosed |
| US-20070069198-A1 | Synthesis of phenyl-substituted fluoranthenes by a diesel-alder reaction and the use thereof | BASF AKTIENGESSLLSCHAFT (DE) | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070069198-A1 | Synthesis of phenyl-substituted fluoranthenes by a diesel-alder reaction and the use thereof | OXER1, DRD3, DRD4 | CES1 695/4885ALDH1A1 393/4885HPGD 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.